Accuray Incorporated
0H8I.L
$0.996 -5.11%
Exchange: LSE | Sector: Healthcare | Industry: Medical Equipment Services
Q1 2025
Published: Nov 6, 2024

Earnings Highlights

  • Revenue of $101.55M down 2.3% year-over-year
  • EPS of $-0.04 decreased by 28.7% from previous year
  • Gross margin of 33.9%
  • Net income of -3.95M
  • "" -
0H8I.L
Accuray Incorporated

Executive Summary

Accuray Incorporated reported QQ1 2025 revenue of USD 101.545 million, essentially flat year-over-year (YoY) at -2.26% but down sharply quarter-over-quarter (QoQ) by -24.38%, signaling typical seasonality and the gradual maturation of project-based revenue streams. Gross profit stood at USD 34.469 million, yielding a gross margin of 33.9%, down about 12.7% YoY and 10.4% QoQ, reflecting a challenging product mix and ongoing cost dynamics in a hardware-heavy business model. The quarter produced an operating loss of USD -2.149 million and a net loss of USD -3.954 million, with adjusted EBITDA of USD 1.090 million. EPS landed at USD -0.0395, marking a deterioration versus prior periods and underscoring near-term profitability pressures even as the company maintains a cash cushion.

Key Performance Indicators

Revenue
Decreasing
101.55M
QoQ: -24.38% | YoY: -2.26%
Gross Profit
Decreasing
34.47M
33.94% margin
QoQ: -10.36% | YoY: -12.72%
Operating Income
Decreasing
-2.15M
QoQ: -131.52% | YoY: -197.11%
Net Income
Decreasing
-3.95M
QoQ: -216.74% | YoY: -33.18%
EPS
Decreasing
-0.04
QoQ: -216.18% | YoY: -28.66%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2025 127.54 0.01 -5.0% View
Q3 2025 113.24 -0.01 +12.0% View
Q2 2025 116.17 0.02 +8.3% View
Q1 2025 101.55 -0.04 -2.3% View
Q4 2024 134.29 0.03 +13.5% View